Zdrowie i gospodarka · 03/01/2013

FDA Extends Comment Period for Public Hearing on Nicotine Replacement Therapies and Smoking-Cessation Products

The Food and Drug Administration (FDA) is extending the comment period for a public hearing notice regarding nicotine replacement therapies and smoking-cessation products, allowing interested persons more time to submit comments. The FDA is seeking input on innovative products and treatments for tobacco dependence, as part of a report to Congress.